CytoMed Therapeutics Limited Expense From Share-based Payment Transactions With Parties Other Than Employees
CytoMed Therapeutics Limited (GDTC) reported Expense From Share-based Payment Transactions With Parties Other Than Employees of SGD 384.95 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithPartiesOtherThanEmployees · last filed 2026-03-31
| Period end | Expense From Share-based Payment Transactions With Parties Other Than Employees 12 month |
|---|---|
| 2025-12-31 | 384.95K SGD 20-F · filed 2026-03-31 |